2019
DOI: 10.1016/j.wnsx.2019.100029
View full text
|
|
Share
M. Neil Woodall, Peter Nakaji, Robert F. Spetzler

Abstract: Background Arteriovenous malformations (AVMs) are a cardinal feature of hereditary hemorrhagic telangiectasia (HHT). However, whether to treat brain AVMs in patients with HHT remains questionable because of the possible risks. Methods We performed a retrospective study of patients with HHT who had been treated for brain AVMs at our institution from January 1, 2003, to December 31, 2016. An institutional database was queried for the phrases “hereditary hemorrhagic telang…

expand abstract